Skip to main content
. 2018 Feb 18;11(2):183–188. doi: 10.18240/ijo.2018.02.01

Figure 5. VIP antagonist up-regulated.

Figure 5

TLR4 (A) and IL-17 (C) mRNA expression after 3d infection. LOX-1 expression (B) was down-regulated after 3d infection. VIP antagonist upregulated MPO levels (D) in BALB/c mice after 3 and 5d infection. aP<0.05, bP<0.001, cP<0.01 vs PBS treatment.